Clinical Trial: A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder.

U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796868) titled 'A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder.' on Jan. 22.

Brief Summary: The study aims to evaluate the efficacy and safety of GW117 Tablets compared to placebo in adults participants with MDD over a period of 8 weeks.

Study Start Date: July 07, 2022

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder (MDD)

Intervention: DRUG: GW117 Tablets

GW117 Tablets 20mg orally once a day

DRUG: GW117 Tablets

GW117 Tablets 20mg*2 orally once a day

DRUG: GW117 Tablets

GW117 Tablets 20mg*3 orally once a day

DRUG: Placebo

placebo orally once a day

Recruitment Status: COMPLETED

Spo...